Tradestie Institutional Equity Comparison Engine

AXNX vs MDT โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

MDT Overall Edge

MDT Captures Institutional Edge (3โ€“1 Pillars ยท 9โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Medtronic plc (MDT) driven by superior Valuation, Growth & Margin, Options & Structure while AXNX counters with relative strength in Momentum & Technical. Fundamentally, AXNX trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus MDT at 16.5x Forward P/E and 20.1% operating margin (+13.7% YoY). In options structure, AXNX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against MDT sits in CONSOLIDATION (15th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner MDT
AXNX N/M vs MDT 16.5x Fwd P/E
Growth & Margin Winner MDT
Op Margin N/A vs 20.1% ยท YoY N/A vs +13.7%
Momentum & Technical Winner AXNX
1Y +16.9% vs -0.4% ยท 52W Pos 50% vs 81%
Options & Structure Winner MDT
UNCLASSIFIED (N/A IV) vs CONSOLIDATION (15th %ile IV)
AXNX US Equity
AXNX
Institutional Equity
$0.83
-8.28% 1D
Market Cap N/A
1M Return -26.54%
1Y Return +16.92%
Forward P/E N/M
Unified AI Score
52.1 / 100 HOLD
Tech 50.0 Fund 50.0 Flow 50.0 Mom 50.0
MDT NYSE
Medtronic plc
Electromedical & Electrotherapeutic Apparatus
$99.94
-0.67% 1D
Market Cap $128.7B
1M Return +3.47%
1Y Return -0.4%
Forward P/E 16.5x
Unified AI Score
44.7 / 100 HOLD
Tech 31.0 Fund 49.0 Flow 72.0 Mom 46.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: AXNX +16.92% MDT -0.4% Spread: +9.47 pp (AXNX Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
AXNX TTM Op. Margin: N/A MDT TTM Op. Margin: 20.1%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AXNX vs MDT. Trailing 12-month operating profitability (AXNX N/A vs MDT 20.1%) and valuation multiples (AXNX N/M vs MDT 16.5x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: AXNX (1) vs MDT (9)
Institutional Metric AXNX MDT Criterion Row Winner
Market Capitalization Scale N/A $128.7B Larger Scale MDT
Trailing P/E Ratio Valuation N/M 24.7x Lower Multiple MDT
Forward P/E Ratio Valuation N/M 16.5x Lower Multiple MDT
Revenue Growth (YoY) Growth N/A +13.7% Higher Growth MDT
Operating Margin (TTM) Profitability N/A 20.1% Higher Margin MDT
Net Profit Margin Profitability N/A 13.9% Higher Margin MDT
Return on Equity (ROE) Capital Efficiency N/A 10.7% Higher ROE MDT
52-Week Range Position Momentum 50% ($0โ€“$1) 81% ($73โ€“$106) Stronger Trend MDT
Beta / 30D Volatility Risk Regime N/A 0.13ฮฒ ยท 30% Vol Lower Realized Risk MDT
Unified Institutional Score Composite Signal 52.1 / 100 (HOLD) 44.7 / 100 (HOLD) Higher Composite AXNX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full AXNX vs MDT Buy Guide
AXNX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live AXNX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
MDT CONSOLIDATION
66d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 15th %ile
IV Regime Compressed (<25th %ile)
Live MDT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither AXNX nor MDT registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.